Vaccine for bluetongue disease employing platinum compounds

Details Vaccine for bluetongue disease employing platinum compounds Vaccine for bluetongue disease employing platinum compounds

1982-06-08

1987-02-24

Rosen, Sam

Drug, bio-affecting and body treating compositions

Lymphokine

435238, A61K 3912, C12N 706

Patent

active

046456660

ABSTRACT:
Vaccine prepared by inactivation of non-enveloped virus with cis-diamino chelated platinous halide in presence of an effective amount of a detergent. Method of inactivation particularly applicable employing a non-ionic detergent in inactivating a double stranded RNA virus.

REFERENCES:
patent: 3847737 (1974-11-01), Kanarek
patent: 4053587 (1977-10-01), Davidson et al.
patent: 4273755 (1981-06-01), Rhoda et al.
patent: 4344935 (1982-08-01), Leclerc et al.
patent: 4370264 (1983-01-01), Kotitschke et al.
Kemeny et al., Am. J. Vet. Res., 22: 921-925 (1961).
Parker et al., Vet. Rec., 96: 284-287 (1975).
Davis et al., Microbiology, Harper and Row, New York, 1973, pp. 1463-1464.
Kutinova et al., Neoplasma (1972) 19: 5.
Davis, Bernard D., and others, Microbiology: Including Immunology and Molecular Genetics, Philadelphia: Harper & Row, 1980, pp. 855 & 1273.

Affiliated with

Also associated with

Rating

Vaccine for bluetongue disease employing platinum compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vaccine for bluetongue disease employing platinum compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine for bluetongue disease employing platinum compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-108493